AbbVie to buy ImmunoGen for $10.1 billion to boost cancer drug portfolio
AbbVie to buy ImmunoGen for $10.1 billion to boost cancer drug portfolio
Finance,Mergers
AbbVie trims full-year profit forecast on higher R&D expenses
AbbVie trims full-year profit forecast on higher R&D expenses
Finance
US FDA approves Genmab-AbbVie's blood cancer therapy
US FDA approves Genmab-AbbVie's blood cancer therapy
Health,Top News
Terms of Service | Privacy Policy
© 2024 Sosao • Com